Key result
Mitral valve repair for non-rheumatic mitral regurgitation demonstrated stable long-term results, with an actuarial survival rate of 83.9% and freedom from reoperation of 84.5% at 10 years.
Why the study?
Does mitral valve repair provide stable long-term outcomes in patients with non-rheumatic mitral regurgitation?
Cohort (n=54)
Does mitral valve repair provide stable long-term outcomes in patients with non-rheumatic mitral regurgitation?
Mitral valve repair for non-rheumatic mitral regurgitation demonstrates low operative mortality and stable long-term survival and freedom from reoperation at 10 years.
Supports durable mitral repair outcomes in non-rheumatic MR; leaves open need for randomized confirmation before practice change.
The durability of mitral valve repaired with reconstructive techniques is variable. If the durability continues to be good, mitral valve repair may be the procedure of choice in many patients with mitral regurgitation. Between December 1970 and June 1993, 54 patients had mitral valve repair for non-rheumatic mitral regurgitation. There were 38 men and 16 women with a mean age of 46.8 (range 19–68) years. The pathology which required surgical treatment was torn chordae in 38 patients, elongation of the chordae in five, valve prolapse without elongation or rupture of the chordae in six, infective endocarditis in three, and annular dilatation in two. Forty-four patients had triangular or quadrangular resection of the mitral leaflet, and seven had annuloplasty alone. Choral reconstruction was performed on three patients. There were no operative deaths. Five patients (9%) died late after operation. The actuarial survival rate and the valve-related death-free rate at 10 years were 83.9% and 90.0%, respectively. Seven patients (13%) required reoperation. Freedom from reoperation at 10 years was 84.5%. Improper evaluation of residual regurgitation during operation and suture dehiscence were the principal causes of reoperation. It was concluded that mitral valve repair for non-rheumatic mitral regurgitation showed low operative mortality and stable long-term results. It is suggested that intraoperative transoesophageal colour Doppler echocardiography provides accurate assessment of mitral valve competence and may be helpful in reducing the need for reoperation.
No takes yet. Share an insight, caveat, or question.
Aoyagi et al. (1995) conducted a cohort in Non-rheumatic mitral regurgitation (n=54). Mitral valve repair was evaluated on Actuarial survival rate at 10 years. Mitral valve repair for non-rheumatic mitral regurgitation demonstrated stable long-term results, with an actuarial survival rate of 83.9% and freedom from reoperation of 84.5% at 10 years.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: